ViaDerma, Inc., a specialty pharmaceutical company, has created a big name for itself for bringing new pharma products using innovative research & development. Founded by the President and CEO, Dr. Christopher Otiko, ViaDerma company has witnessed immense growth over the last 12 months.
Despite going through many major challenges during 2020, ViaDerma has managed to scale new heights in the pharmaceutical world by taking long-strides. Now, Dr. Christopher Otiko, president of ViaDerma eyes on taking his company to new heights with explosive growth in 2021.
ViaDerma, Inc. officially launched two important products namely, 55ml Vitastem spray bottle and Liberdol (a pain relief product). After the testing by many reputed hospitals, the FDA granted approval for Vitastem which is a topical antibiotic suitable for different treatments of large wounds.
The company has already secured a line of credit for financing future manufacturing and it expects its sale to reach 500,000 units in 2021. Vitastem is a major product that is tested successfully by a large national hospital chain and a major health insurance company.
The company is going to announce the size of the initial purchase for this product after the final stages of discussions with a major midwestern university regarding the initial product purchase. ViaDerma, Inc. has begun discussions with a major global medical nonprofit that has expressed its interest to purchase Vitastem for treating patients.
ViaDerma CEO is hopeful of exceeding all the previous limits of growth of his company in 2021. And it is simply due to the release of exceptional pharmaceutical products in various fields of medicine ranging from infectious diseases and wound care.